• Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +2
  • Belatacept Dose Reduction Safety in Kidney Transplant Recipients with a Well-Matched Donor

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Molecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate

    Not yet recruiting

    2 1 1 1
    Denmark
  • Maribavir for High Epstein-Barr Virus Infection in Young Adult Kidney Transplant Recipients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Verteporfin for Scar Prevention in Patients After Surgical Wounds

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Denmark
  • DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

    Not yet recruiting

    2 1 1
    France Germany Italy Poland Spain
  • Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma After Second-Line Platinum-Based Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • Vasopressin Versus Norepinephrine for Patients with Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy Surgery

    Not yet recruiting

    3 1 1 1
    France
  • Venetoclax Added to Standard Chemotherapy and Midostaurin for Patients with FLT3-Mutated Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

    Not yet recruiting

    2 1 1
    Investigated diseases:
    France

powered by